These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38254626)

  • 1. Evidence of Guanidines Potential against
    Dos Anjos LR; de Souza VMR; Machado YAA; Partite VM; Aufy M; Dias Lopes G; Studenik C; Alves CR; Lubec G; Gonzalez ERP; Rodrigues KADF
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylases inhibitors as new potential drugs against Leishmania braziliensis, the main causative agent of new world tegumentary leishmaniasis.
    Ângelo de Souza L; Silva E Bastos M; de Melo Agripino J; Souza Onofre T; Apaza Calla LF; Heimburg T; Ghazy E; Bayer T; Ferraz da Silva VH; Dutra Ribeiro P; Licursi de Oliveira L; Costa Bressan G; de Almeida Lamêgo MR; Silva-Júnior A; de Souza Vasconcellos R; Suarez-Fontes AM; Almeida-Silva J; Vannier-Santos MA; Pierce R; Sippl W; Lopes Rangel Fietto J
    Biochem Pharmacol; 2020 Oct; 180():114191. PubMed ID: 32777278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Selective and Low-Toxic Inhibitor of
    Moreira VP; da Silva Mela MF; Anjos LRD; Saraiva LF; Arenas Velásquez AM; Kalaba P; Fabisiková A; Clementino LDC; Aufy M; Studenik C; Gajic N; Prado-Roller A; Magalhães A; Zehl M; Figueiredo ID; Baviera AM; Cilli EM; Graminha MAS; Lubec G; Gonzalez ERP
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pterocarpanquinone LQB-118 induces apoptosis in Leishmania (Viannia) braziliensis and controls lesions in infected hamsters.
    Costa L; Pinheiro RO; Dutra PM; Santos RF; Cunha-Júnior EF; Torres-Santos EC; da Silva AJ; Costa PR; Da-Silva SA
    PLoS One; 2014; 9(10):e109672. PubMed ID: 25340550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N, N', N″-trisubstituted guanidines: Synthesis, characterization and evaluation of their leishmanicidal activity.
    do Espírito Santo RD; Velásquez ÁMA; Passianoto LVG; Sepulveda AAL; da Costa Clementino L; Assis RP; Baviera AM; Kalaba P; Dos Santos FN; Éberlin MN; da Silva GVJ; Zehl M; Lubec G; Graminha MAS; González ERP
    Eur J Med Chem; 2019 Jun; 171():116-128. PubMed ID: 30913526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low doses of 3-phenyl-lawsone or meglumine antimoniate delivery by tattooing route are successful in reducing parasite load in cutaneous lesions of
    Meira RMV; Gomes SLDS; Schaeffer E; Da Silva T; Brito ACS; Siqueira LM; Inácio JD; Almeida-Amaral EE; Da-Cruz AM; Bezerra-Paiva M; Neves RH; Rodrigues LS; Dutra PML; Costa PRR; da Silva AJM; Da-Silva SAG
    Front Cell Infect Microbiol; 2023; 13():1025359. PubMed ID: 36743305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alkylaminoalkanethiosulfuric acids exhibit in-vitro antileishmanial activity against Leishmania (Viannia) braziliensis: a new perspective for use of these schistosomicidal agents.
    Porcino GN; Antinarelli LMR; Maia ACRG; Faria-Pinto P; Taunay-Rodrigues A; Zech Coelho PM; Nelson DL; Penido MLO; Coimbra ES; Vasconcelos EG
    J Pharm Pharmacol; 2019 Dec; 71(12):1784-1791. PubMed ID: 31579947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morita-Baylis-Hillman adduct shows in vitro activity against Leishmania (Viannia) braziliensis associated with a reduction in IL-6 and IL-10 but independent of nitric oxide.
    Amorim FM; Rodrigues YK; Barbosa TP; Néris PL; Caldas JP; Sousa SC; Leite JA; Rodrigues-Mascarenhas S; Vasconcellos ML; Oliveira MR
    Parasitology; 2013 Jan; 140(1):29-38. PubMed ID: 22906971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
    Santos DM; Petersen AL; Celes FS; Borges VM; Veras PS; de Oliveira CI
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3275. PubMed ID: 25340794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.
    Giudice A; Camada I; Leopoldo PT; Pereira JM; Riley LW; Wilson ME; Ho JL; de Jesus AR; Carvalho EM; Almeida RP
    BMC Infect Dis; 2007 Feb; 7():7. PubMed ID: 17316450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.
    de Mello TF; Bitencourt HR; Pedroso RB; Aristides SM; Lonardoni MV; Silveira TG
    Exp Parasitol; 2014 Jan; 136():27-34. PubMed ID: 24269198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of proteins secreted by Leishmania (Viannia) braziliensis strains associated to distinct clinical manifestations of American Tegumentary Leishmaniasis.
    Rodríguez-Vega A; Losada-Barragán M; Berbert LR; Mesquita-Rodrigues C; Bombaça ACS; Menna-Barreto R; Aquino P; Carvalho PC; Padrón G; de Jesus JB; Cuervo P
    J Proteomics; 2021 Feb; 232():104077. PubMed ID: 33309930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine macrophages do not support the proliferation of Leishmania (Viannia) braziliensis amastigotes even in absence of nitric oxide and presence of high arginase activity.
    Teixeira MV; Soares SAE; Souza VA; de Souza Marques AM; de Almeida Soares CM; Baeza LC; de Oliveira MAP
    Parasitol Res; 2022 Oct; 121(10):2891-2899. PubMed ID: 35939146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibitory effect of aluminum phthalocyanine tetrasulfonate chloride against Leishmania (Viannia) Peruviana and Leishmania (Viannia) Braziliensis.
    Izarra-Rojas KV; Rojas-Palomino N; Gonzales-Medrano JL; Minaya-Gómez G; Berrocal-Huallpa A; Santiago-Contreras J; León-Quispe J
    Rev Peru Med Exp Salud Publica; 2020 Dec; 37(3):462-470. PubMed ID: 33295548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of oral quercetin in hamsters infected with
    Dos Santos RF; Da Silva T; Brito ACS; Inácio JD; Ventura BD; Mendes MAP; Azevedo BF; Siqueira LM; Almeida-Amaral EE; Dutra PML; Da-Silva SAG
    Front Cell Infect Microbiol; 2022; 12():1059168. PubMed ID: 36710981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.
    Souza AS; Giudice A; Pereira JM; Guimarães LH; de Jesus AR; de Moura TR; Wilson ME; Carvalho EM; Almeida RP
    BMC Infect Dis; 2010 Jul; 10():209. PubMed ID: 20633260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-548d-3p Alters Parasite Growth and Inflammation in
    Souza MA; Ramos-Sanchez EM; Muxel SM; Lagos D; Reis LC; Pereira VRA; Brito MEF; Zampieri RA; Kaye PM; Floeter-Winter LM; Goto H
    Front Cell Infect Microbiol; 2021; 11():687647. PubMed ID: 34178725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.